Galectin Therapeutics Stock (NASDAQ: GALT) stock price, news, charts, stock research, profile.
Open | $2.59 |
Close | $2.57 |
Volume / Avg. | 97.96K / 184.28K |
Day Range | 2.56 - 2.70 |
52 Wk Range | 1.35 - 4.27 |
Market Cap | $159.72M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 15.31% |
Days to Cover | 25.57 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Galectin Therapeutics (NASDAQ:GALT) through any online brokerage.
Other companies in Galectin Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Innate Pharma (NASDAQ:IPHA), Skye Bioscience (NASDAQ:SKYE), Adverum Biotechnologies (NASDAQ:ADVM) and Adicet Bio (NASDAQ:ACET).
There is no analysis for Galectin Therapeutics.
Galectin Therapeutics has a consensus price target of $11.00.
The stock price for Galectin Therapeutics (NASDAQ: GALT) is $2.57 last updated July 29, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Galectin Therapeutics.
Galectin Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Galectin Therapeutics.
Galectin Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.